B. Braun Medical Inc. announced the FDA approval of Sugammadex Injection, 200 mg/2 mL (100 mg/mL), AP-rated generic BRIDION®1* (Sugammadex Injection) in the U.S. market.
LEESBURG, Fla., July 8, 2026 /PRNewswire/ — RunStar®, the brand behind innovative at-home health devices designed to simplify personalized health tracking, is expanding its line with the launch of its newest device. The RunStar Smart Blood Pressure Monitor (BP-206) builds on RunStar’s growing portfolio of health monitoring technology, offering users an intuitive way to measure, track, and better understand their blood pressure from home.
Carea, the pregnancy and postnatal wellbeing app, has launched its new Contraction Timer designed to support women during labour through a combination of contraction tracking, labour pattern analysis and wellbeing tools.
Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool – the first in Europe and the United Kingdom to detect breast cancer using magnetic resonance imaging – which automatically identifies suspected lesions on breast MRI.
https://med-techinsights.com/2026/04/22/new-tool-launches-to-support-women-through-post-loss-journey/
Fentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics
AUSTIN, Texas, March 31, 2026 /PRNewswire/ — Genesys Spine today announced the successful completion of the first surgical procedure utilizing the SIros-X System, a next-generation solution designed to deliver precision, adaptability, and control for complex sacroiliac joint fusion and pelvic fixation. The inaugural case was performed by Scott L. Parker, M.D., at Ascension Saint Thomas Hospital Midtown, Nashville, TN, marking an important milestone as the system begins clinical use.
Procept BioRobotics (Nasdaq:PRCT) today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
The dressing combines several technologies to minimise leakage, reduce dressing changes, and protect vulnerable skin.
WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ — Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.